An Australian pharmaceutical company, will begin its experimental swine flu vaccine trials at Royal Adelaide Hospital on 240 volunteers between the ages of 18 and 64. Dr. Russell Basser, the company"s global director of clinical development, has said that depending on the properties of the influenza, patients may need higher dosing to get the desired immune response.